TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

GABELLI FUNDS LLC's Holding History (CIK: 0001081407)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,400,000 Value ($000) $3,382 Avg Close — Range —